July 17th 2024
Whether a patient has a diagnosis of cPTSD, BPD, or some combination of both, treatment should be considered multifaceted and overlapping. Learn more in this Special Report article.
The Role of Psychedelics in Psychiatry: A Conversation With Rachel Dalthorp, MD, MHSA
June 4th 2024The FDA Meeting of the Psychopharmacologic Drugs Advisory Committee evaluating the New Drug Application for MDMA is happening now. How do clinicians feel about this potential treatment for PTSD?
Read More